Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (8): 696-701.doi: 10.35541/cjd.20201084
• Original Articles • Previous Articles Next Articles
Lan Xiaoou1, Wang Qiang1, Li Shangyun1, Sun Xiaodong1, Song Danyang1, Li Jiawei2, Song Guoqiang1, Hu Lanting1, Geng Long3
Received:
2020-11-12
Revised:
2021-05-27
Online:
2021-08-15
Published:
2021-08-02
Contact:
Geng Long; Wang Qiang
E-mail:genglong99@126.com; swepco@126.com
Supported by:
Lan Xiaoou, Wang Qiang, Li Shangyun, Sun Xiaodong, Song Danyang, Li Jiawei, Song Guoqiang, Hu Lanting, Geng Long. Topical shikonin: intervention effect on an imiquimod-induced psoriasis-like mouse model and influence on CEBPD expression[J]. Chinese Journal of Dermatology, 2021, 54(8): 696-701.doi:10.35541/cjd.20201084
[1] | Lan W, Wan S, Gu W, et al. Mechanisms behind the inhibition of lung adenocarcinoma cell by shikonin[J]. Cell Biochem Biophys, 2014,70(2):1459⁃1467. doi: 10.1007/s12013⁃014⁃0083⁃5. |
[2] | Gong K, Zhang Z, Chen Y, et al. Extracellular signal⁃regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin⁃induced autophagy in human hepatocellular carcinoma[J]. Eur J Pharmacol, 2014,738:142⁃152. doi: 10.1016/ j.ejphar.2014.05.034. |
[3] | Qiu HY, Fu JY, Yang MK, et al. Identification of new shikonin derivatives as STAT3 inhibitors[J]. Biochem Pharmacol, 2017,146:74⁃86. doi: 10.1016/j.bcp.2017.10.009. |
[4] | Li W, Zhang C, Ren A, et al. Shikonin suppresses skin carcinogenesis via inhibiting cell proliferation[J/OL]. PLoS One, 2015,10(5):e0126459[2019⁃08⁃31]. https://sci⁃hub.ren/10.1371/journal.pone.0126459. doi: 10.1371/journal.pone.0126459. |
[5] | Xu Y, Xu X, Gao X, et al. Shikonin suppresses IL⁃17⁃induced VEGF expression via blockage of JAK2/STAT3 pathway[J]. Int Immunopharmacol, 2014,19(2):327⁃333. doi: 10.1016/j.intimp. 2014.01.027. |
[6] | Liu L, Wu Y, Cao K, et al. Shikonin inhibits IFN⁃γ⁃induced K17 over⁃expression of HaCaT cells by interfering with STAT3 signaling[J]. Int J Clin Exp Pathol, 2015,8(8):9202⁃9207. |
[7] | Yu YJ, Xu YY, Lan XO, et al. Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP⁃δ upregulation[J]. Int Immunopharmacol, 2019,72:511⁃521. doi: 10.1016/j.intimp. 2019.04.047. |
[8] | Lan XO, Wang HX, Qi RQ, et al. Shikonin inhibits CEBPD downregulation in IL⁃17⁃treated HaCaT cells and in an imiquimod⁃induced psoriasis model[J]. Mol Med Rep, 2020,22(3):2263⁃2272. doi: 10.3892/mmr.2020.11315. |
[9] | 王燕芹, 李新新, 薛海波, 等. γ分泌酶抑制剂阻断Notch⁃Hes1信号通路对银屑病样皮炎小鼠γδT17细胞表达的影响[J]. 中华皮肤科杂志, 2019,52(11):801⁃807. doi: 10.35541/cjd. 20190241. |
[10] | Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model[J]. Nat Med, 2005,11(1):43⁃49. doi: 10.1038/nm1162. |
[11] | Yang L, Li B, Dang E, et al. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3[J]. J Dermatol Sci, 2016,81(2):85⁃92. doi: 10.1016/j.jdermsci.2015.11.007. |
[12] | Korn T, Bettelli E, Gao W, et al. IL⁃21 initiates an alternative pathway to induce proinflammatory T(H)17 cells[J]. Nature, 2007,448(7152):484⁃487. doi: 10.1038/nature05970. |
[13] | Ikezoe T, Gery S, Yin D, et al. CCAAT/enhancer⁃binding protein delta: a molecular target of 1,25⁃dihydroxyvitamin D3 in androgen⁃responsive prostate cancer LNCaP cells[J]. Cancer Res, 2005,65(11):4762⁃4768. doi: 10.1158/0008⁃5472.CAN⁃03⁃3619. |
[14] | Alonzi T, Maritano D, Gorgoni B, et al. Essential role of STAT3 in the control of the acute⁃phase response as revealed by inducible gene inactivation [correction of activation] in the liver[J]. Mol Cell Biol, 2001,21(5):1621⁃1632. doi: 10.1128/MCB.21. 5.1621⁃1632.2001. |
[15] | Tang D, Sivko GS, DeWille JW. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM⁃52PE human breast cancer cell line and in primary breast tumors[J]. Breast Cancer Res Treat, 2006,95(2):161⁃170. doi: 10.1007/s10549⁃005⁃9061⁃3. |
[16] | Pan YC, Li CF, Ko CY, et al. CEBPD reverses RB/E2F1⁃mediated gene repression and participates in HMDB⁃induced apoptosis of cancer cells[J]. Clin Cancer Res, 2010,16(23):5770⁃5780. doi: 10.1158/1078⁃0432.CCR⁃10⁃1025. |
[17] | O′Rourke J, Yuan R, DeWille J. CCAAT/enhancer⁃binding protein⁃delta (C/EBP⁃delta) is induced in growth⁃arrested mouse mammary epithelial cells[J]. J Biol Chem, 1997,272(10):6291⁃6296. doi: 10.1074/jbc.272.10.6291. |
[1] | Wang Yue, Yan Yulin. Analysis of adverse drug reactions and reasons for drug discontinuation during acitretin therapy in 171 patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2022, 55(3): 242-245. |
[2] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263. |
[3] | Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250. |
[4] | Wang Xiaowen, Li Ruoyu. Superficial fungal infections in psoriasis patients treated with IL-17 related biological agents and their management [J]. Chinese Journal of Dermatology, 2022, 55(3): 272-275. |
[5] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[6] | Zhang Tingting, Zhu Fengyi, Yang Mei, Zhang Ping, Xia Ping, Zhou Xiaoyong. Clinical efficacy and safety of secukinumab in the treatment of 7 cases of erythrodermic psoriasis [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210644-e20210644. |
[7] | Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184. |
[8] | Zhao Ying, Wang Juanjuan, Ji Jiang, Su Wenxing, Wei Yuqian, Leng Hong, Ding Yujie, Shi Xin. Interleukin-17A-mediated psoriasis and cardiovascular comorbidities [J]. Chinese Journal of Dermatology, 2022, 55(1): 76-79. |
[9] | Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75. |
[10] | Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210420-e20210420. |
[11] | Lin Luyang, Chen Zhengliang, Zhang Xibao. Major immune-related cells in psoriasis vulgaris lesions [J]. Chinese Journal of Dermatology, 2021, 54(9): 830-834. |
[12] | Ying Jieya, Xiang Wenzhong, Song Xiuzu. Metabolic syndrome and skin diseases [J]. Chinese Journal of Dermatology, 2021, 54(7): 642-645. |
[13] | Yu Yingyuan, Li Ying, Yu Zengyang, Zheng Jianfeng, Zhang Xilin, Ding Yangfeng, Shi Yuling, . Efficacy and safety of infliximab in the treatment of severe plaque psoriasis and its effect on the expression of programmed cell death-1 and programmed cell death ligand-1 [J]. Chinese Journal of Dermatology, 2021, 54(7): 590-596. |
[14] | Committee on Psoriasis, Chinese Society of Dermatology, Committee on Children, Chinese Society of Dermatology. Consensus on the diagnosis and treatment of childhood psoriasis in China (2021) [J]. Chinese Journal of Dermatology, 2021, 54(7): 559-581. |
[15] | Liu Junlin, Wang Wei, Cao Zhirui, Liu Kun, Wan Duoyan, Wu Zhiming, Luo Yang, Xiao Chuanliu, Liu Lu, Yin Mei. Analysis of relationship between psoriasis vulgaris and vitamin D receptor gene in a Han population in Hainan Province based on targeted capture sequencing [J]. Chinese Journal of Dermatology, 2021, 54(7): 597-604. |
|